Key FDA Initiatives Your Company Should Address – Why, When and How?

WHAT TO EXPECT AND HOW TO RE-ADJUST COMPLIANCE PROTOCOLS - September 2014
by Lawrence Reichman, Partner at Perkins Coie LLP (Portland, OR)

Part of

Session: Key FDA Initiatives Your Company Should Address – Why, When and How?

Part of Conference:

September 29 – 30, 2014

Chicago, IL

Purchase Products